Gender issues in antiepileptogenic treatments.

@article{Pitknen2014GenderII,
  title={Gender issues in antiepileptogenic treatments.},
  author={Asla Pitk{\"a}nen and Noora Huusko and Xavier Ekolle Ndode-Ekane and Jenni Kyyri{\"a}inen and Anssi Lipponen and Anu Lipsanen and Alejandra Sierra and Tamuna Bolkvadze},
  journal={Neurobiology of disease},
  year={2014},
  volume={72 Pt B},
  pages={224-32}
}
Disease modification of epilepsy refers to the alleviation of epileptogenesis or comorbidities after genetic or acquired epileptogenic brain insults. There are currently 30 proof-of-concept experimental pharmacologic studies that have demonstrated some beneficial disease-modifying effects. None of these studies, however, has yet passed from the laboratory… CONTINUE READING